Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Nicorette Microtab Lemon

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Nikotin Testmiljö

Nikotin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33.

  2. Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS One. 2017;12(2):e0170946.

  3. Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mackenbach JP, Moll HA et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol. 2007;165(10):1207-15.

  4. Tatiana M Anderson, Juan M Lavista Ferres, Shirley You Ren, Rachel Y Moon, Richard D Goldstein, Jan-Marino Ramirez, Edwin A Mitchell. Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death. Pediatrics. 2019;143(4):e20183325.

  5. Vardavas CI, Hohmann C, Patelarou E, Martinez D, Henderson AJ, Granell R et al. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur Respir J. 2016;48(1):115-24.

  6. Baba S, Wikström AK, Stephansson O, Cnattingius S. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob Res. 2014;16(1):78-83.

  7. Gunnerbeck A, Wikström AK, Bonamy AK, Wickström R, Cnattingius S. Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics. 2011;128(3):503-9.

  8. England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939-43.

  9. Regan AK, Bombard JM, O'Hegarty MM, Smith RA, Tong VT. Adverse Birth Outcomes Associated With Prepregnancy and Prenatal Electronic Cigarette Use. Obstet Gynecol. 2021;138(1):85-94.

  10. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control. 2000;9 Suppl 3(3):III91-4.

  11. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116(2):364-74.

  12. Kreyberg I, Nordhagen LS, Bains KES, Alexander J, Becher R, Carlsen KH et al. An update on prevalence and risk of snus and nicotine replacement therapy during pregnancy and breastfeeding. Acta Paediatr. 2019;108(7):1215-1221.

  13. Wickström R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol. 2007;5(3):213-22.

  14. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics. 2015;135(5):859-67.

  15. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Stillbirth Among Women Prescribed Nicotine Replacement Therapy in Pregnancy: Analysis of a Large UK Pregnancy Cohort. Nicotine Tob Res. 2019;21(4):409-415.

  16. K Strandberg-Larsen, M Tinggaard, A-M Nybo Andersen, J Olsen, M Grønbaek. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study. BJOG. 2008 08 20;115(11):1405-10.

  17. Lassen TH, Madsen M, Skovgaard LT, Strandberg-Larsen K, Olsen J, Andersen AM. Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol. 2010;24(3):272-81.

  18. Siu AL, US Preventive Services Task Force. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622-34.

  19. Turner E, Jones M, Vaz LR, Coleman T. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine Tob Res. 2019;21(8):1001-1010.

  20. Claire R, Chamberlain C, Davey MA, Cooper SE, Berlin I, Leonardi-Bee J et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020;3(3):CD010078.

  1. Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33.
  2. Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS One. 2017;12(2):e0170946.
  3. Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mackenbach JP, Moll HA et al. Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol. 2007;165(10):1207-15.
  4. Tatiana M Anderson, Juan M Lavista Ferres, Shirley You Ren, Rachel Y Moon, Richard D Goldstein, Jan-Marino Ramirez, Edwin A Mitchell. Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death. Pediatrics. 2019;143(4):e20183325.
  5. Vardavas CI, Hohmann C, Patelarou E, Martinez D, Henderson AJ, Granell R et al. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur Respir J. 2016;48(1):115-24.
  6. Baba S, Wikström AK, Stephansson O, Cnattingius S. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob Res. 2014;16(1):78-83.
  7. Gunnerbeck A, Wikström AK, Bonamy AK, Wickström R, Cnattingius S. Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics. 2011;128(3):503-9.
  8. England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939-43.
  9. Regan AK, Bombard JM, O'Hegarty MM, Smith RA, Tong VT. Adverse Birth Outcomes Associated With Prepregnancy and Prenatal Electronic Cigarette Use. Obstet Gynecol. 2021;138(1):85-94.
  10. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control. 2000;9 Suppl 3(3):III91-4.
  11. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116(2):364-74.
  12. Kreyberg I, Nordhagen LS, Bains KES, Alexander J, Becher R, Carlsen KH et al. An update on prevalence and risk of snus and nicotine replacement therapy during pregnancy and breastfeeding. Acta Paediatr. 2019;108(7):1215-1221.
  13. Wickström R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol. 2007;5(3):213-22.
  14. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics. 2015;135(5):859-67.
  15. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Stillbirth Among Women Prescribed Nicotine Replacement Therapy in Pregnancy: Analysis of a Large UK Pregnancy Cohort. Nicotine Tob Res. 2019;21(4):409-415.
  16. K Strandberg-Larsen, M Tinggaard, A-M Nybo Andersen, J Olsen, M Grønbaek. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study. BJOG. 2008 08 20;115(11):1405-10.
  17. Lassen TH, Madsen M, Skovgaard LT, Strandberg-Larsen K, Olsen J, Andersen AM. Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol. 2010;24(3):272-81.
  18. Siu AL, US Preventive Services Task Force. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622-34.
  19. Turner E, Jones M, Vaz LR, Coleman T. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine Tob Res. 2019;21(8):1001-1010.
  20. Claire R, Chamberlain C, Davey MA, Cooper SE, Berlin I, Leonardi-Bee J et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020;3(3):CD010078.